Cargando…

Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer

Downregulation of human leukocyte antigen (HLA) class I is one mechanism of escaping anti-tumor immunity by tumor cells. This study was conducted to compare HLA class I expression in ductal carcinoma in situ (DCIS) and invasive breast carcinoma (IBC) and to evaluate its association with immune cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Song-Hee, Kim, Milim, Chung, Yul Ri, Woo, Ji Won, Choi, Hye Yeon, Park, So Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701770/ https://www.ncbi.nlm.nih.gov/pubmed/36437379 http://dx.doi.org/10.1038/s41598-022-24890-3

Ejemplares similares

Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers
por: Woo, Ji Won, et al.
Publicado: (2020)

Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast
por: Kim, Milim, et al.
Publicado: (2021)

Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer
por: Ahn, Soomin, et al.
Publicado: (2020)

Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast
por: Kim, Milim, et al.
Publicado: (2020)

Clinical implications of changes in the diversity of c-MYC copy number variation after neoadjuvant chemotherapy in breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2018)

Mammary Carcinoma Arising in Microglandular Adenosis: A Report of Five Cases
por: Kim, Mimi, et al.
Publicado: (2017)

Interobserver Variability of Ki-67 Measurement in Breast Cancer
por: Chung, Yul Ri, et al.
Publicado: (2016)

Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience
por: Kim, Milim, et al.
Publicado: (2018)

Benign Intraductal Papilloma without Atypia on Core Needle Biopsy Has a Low Rate of Upgrading to Malignancy after Excision
por: Han, Song-Hee, et al.
Publicado: (2018)

Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis
por: Andersson, Emilia, et al.
Publicado: (2015)

iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity
por: Suzuki, Daisuke, et al.
Publicado: (2019)

A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method
por: Jang, Min Hye, et al.
Publicado: (2017)

HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape
por: Perea, Francisco, et al.
Publicado: (2017)

HLA Class I Expression Is Associated with DNA Damage and Immune Cell Infiltration into Dysplastic and Neoplastic Lesions in Ulcerative Colitis
por: Okami, Haruka, et al.
Publicado: (2023)

Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer
por: Ahn, Soomin, et al.
Publicado: (2018)

MicroRNA-222 Expression as a Predictive Marker for Tumor Progression in Hormone Receptor-Positive Breast Cancer
por: Han, Song-Hee, et al.
Publicado: (2017)

Clinical implication of HLA class I expression in breast cancer
por: Kaneko, Koichi, et al.
Publicado: (2011)

The Association of Estrogen Receptor Activity, Interferon Signaling, and MHC Class I Expression in Breast Cancer
por: Song, In Hye, et al.
Publicado: (2022)

Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
por: Woo, Ji Won, et al.
Publicado: (2019)

Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance
por: Gwak, Jae Moon, et al.
Publicado: (2017)

The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer
por: Santegoets, Saskia J., et al.
Publicado: (2022)

Identifying the immune interactions underlying HLA class I disease associations
por: Debebe, Bisrat J, et al.
Publicado: (2020)

HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease
por: Weider, Therese, et al.
Publicado: (2020)

Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population.
por: Han, Hoon, et al.
Publicado: (2003)

Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling
por: Park, In Ah, et al.
Publicado: (2017)

Association of HLA-A and Non-Classical HLA Class I Alleles
por: Carlini, Federico, et al.
Publicado: (2016)

Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes
por: Kim, Milim, et al.
Publicado: (2018)

KIR-HLA class I combinations in JIA-associated uveitis
por: Parsa, Miriam, et al.
Publicado: (2012)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer
por: Ren, Yingxue, et al.
Publicado: (2020)

HLA Class I Allele Frequencies in Southern Iranian Women with Breast Cancer
por: Razmkhah, Mahboobeh, et al.
Publicado: (2013)

HLA class I allele promiscuity revisited
por: Rao, Xiangyu, et al.
Publicado: (2011)

The pockets guide to HLA class I molecules
por: Nguyen, Andrea T., et al.
Publicado: (2021)

Invasive Cribriform Carcinoma Arising in Malignant Phyllodes Tumor of Breast: A Case Report
por: Choi, Yoomi, et al.
Publicado: (2012)

HLA Class II Histocompatibility Antigen γ Chain (CD74) Expression Is Associated with Immune Cell Infiltration and Favorable Outcome in Breast Cancer
por: Noer, Julie B., et al.
Publicado: (2021)

Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2021)

HLA-Clus: HLA class I clustering based on 3D structure
por: Shen, Yue, et al.
Publicado: (2023)

A novel role of HLA class I in the pathology of medulloblastoma
por: Smith, Courtney, et al.
Publicado: (2009)

Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule
Publicado: (1990)

Expression of HLA Class I and HLA Class II by Tumor Cells in Chinese Classical Hodgkin Lymphoma Patients
por: Huang, Xin, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_rskj519eq42qgm8rhbfa6d6hg2